Vermedx, a Burlington, VT-based provider of information technology tools initially for the diabetes care market, has raised $500,000 in a Series A financing, the company reported this week. FreshTracks Capital, a venture firm based in Shelburne, VT, led the financing, which is intended to provide Vermedx with funds to enhance marketing efforts and continue to develop products. The company, formed in 2006 with technology from the University of Vermont, has developed software used to collect diabetic patients’ blood test results from laboratories, generate reports based on the lab data, and support outreach to patients whose lab data indicates that they need immediate medical treatment.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
